Tamoxifen flare in advanced endometrial carcinoma

B. J. Brooks; M. E. Lippman

doi:10.1200/JCO.1985.3.2.222

Tamoxifen flare in advanced endometrial carcinoma

B. J. Brooks, M. E. Lippman

Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Tamoxifen citrate has recently been shown to be effective palliative therapy in advanced endometrial carcinoma. Flare reactions from tamoxifen are well known in treatment of metastatic breast carcinoma and are not an indication for stopping therapy. We report a patient being treated with tamoxifen for advanced endometrial cancer who developed acute abdominal pain as a manifestation of a flare reaction and the significance of this observation.

Original language	English (US)
Pages (from-to)	222-223
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	3
Issue number	2
DOIs	https://doi.org/10.1200/JCO.1985.3.2.222
State	Published - Jan 1 1985

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.1985.3.2.222

Cite this

@article{fecc377081fb492daae181ad09fc9d91,

title = "Tamoxifen flare in advanced endometrial carcinoma",

abstract = "Tamoxifen citrate has recently been shown to be effective palliative therapy in advanced endometrial carcinoma. Flare reactions from tamoxifen are well known in treatment of metastatic breast carcinoma and are not an indication for stopping therapy. We report a patient being treated with tamoxifen for advanced endometrial cancer who developed acute abdominal pain as a manifestation of a flare reaction and the significance of this observation.",

author = "Brooks, {B. J.} and Lippman, {M. E.}",

year = "1985",

month = jan,

day = "1",

doi = "10.1200/JCO.1985.3.2.222",

language = "English (US)",

volume = "3",

pages = "222--223",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

TY - JOUR

T1 - Tamoxifen flare in advanced endometrial carcinoma

AU - Brooks, B. J.

AU - Lippman, M. E.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Tamoxifen citrate has recently been shown to be effective palliative therapy in advanced endometrial carcinoma. Flare reactions from tamoxifen are well known in treatment of metastatic breast carcinoma and are not an indication for stopping therapy. We report a patient being treated with tamoxifen for advanced endometrial cancer who developed acute abdominal pain as a manifestation of a flare reaction and the significance of this observation.

AB - Tamoxifen citrate has recently been shown to be effective palliative therapy in advanced endometrial carcinoma. Flare reactions from tamoxifen are well known in treatment of metastatic breast carcinoma and are not an indication for stopping therapy. We report a patient being treated with tamoxifen for advanced endometrial cancer who developed acute abdominal pain as a manifestation of a flare reaction and the significance of this observation.

UR - http://www.scopus.com/inward/record.url?scp=0021943724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021943724&partnerID=8YFLogxK

U2 - 10.1200/JCO.1985.3.2.222

DO - 10.1200/JCO.1985.3.2.222

M3 - Article

C2 - 2578557

AN - SCOPUS:0021943724

VL - 3

SP - 222

EP - 223

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 2

ER -

Tamoxifen flare in advanced endometrial carcinoma

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this